Caricamento...
Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides
Romidepsin belongs to a class of medications called histone deacetylase inhibitors and is currently approved for treatment of cutaneous and peripheral T-cell lymphomas. Romidepsin was previously investigated for the treatment of chronic lymphocytic leukemia (CLL), and demonstrated potential benefit,...
Salvato in:
| Pubblicato in: | Hematol Rep |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
PAGEPress Publications, Pavia, Italy
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136743/ https://ncbi.nlm.nih.gov/pubmed/27994839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6840 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|